Ultragenyx to Present at Upcoming Investor Conferences
March 02 2017 - 8:30AM
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical
company focused on the development of novel products for rare and
ultra-rare diseases, will present at the following investor
conferences:
- Shalini Sharp, the company’s Chief Financial Officer, will
present at the Cowen and Company 37th Annual Health Care
Conference on Tuesday, March 7, 2017 at 8:00 am ET in Boston,
MA.
- Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive
Officer, will present at the Barclays Global Healthcare Conference
on Wednesday, March 15, 2017 at 11:15 am ET in Miami, FL.
The live and archived webcasts of the company presentations will
be accessible from the company’s website at
http://ir.ultragenyx.com/events.cfm. The replays will be available
for 90 days.
About Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company
committed to bringing to market novel products for the treatment of
rare and ultra-rare diseases, with a focus on serious, debilitating
genetic diseases. Founded in 2010, the company has rapidly built a
diverse portfolio of product candidates with the potential to
address diseases for which the unmet medical need is high, the
biology for treatment is clear, and for which there are no approved
therapies.
The company is led by a management team experienced in the
development and commercialization of rare disease therapeutics.
Ultragenyx’s strategy is predicated upon time and cost-efficient
drug development, with the goal of delivering safe and effective
therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company’s
website at www.ultragenyx.com.
Contact Ultragenyx Pharmaceutical Inc.
Investors & Media
Ryan Martins
844-758-7273
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Apr 2023 to Apr 2024